A. Melander

1.2k total citations
36 papers, 704 citations indexed

About

A. Melander is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, A. Melander has authored 36 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 10 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Pharmacology. Recurrent topics in A. Melander's work include Inflammatory mediators and NSAID effects (8 papers), Analytical Methods in Pharmaceuticals (7 papers) and Diabetes Treatment and Management (6 papers). A. Melander is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Analytical Methods in Pharmaceuticals (7 papers) and Diabetes Treatment and Management (6 papers). A. Melander collaborates with scholars based in Sweden, Denmark and United States. A. Melander's co-authors include Ulf Lindblad, L. Råstam, Jonas Ranstam, Carl Johan Östgren, E Wahlin‐Boll, Peter Seideman, F. Sundler, E. W�hlin-Boll, Tony Rydberg and Bengt Scherstén and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Endocrinology and Diabetologia.

In The Last Decade

A. Melander

34 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Melander Sweden 18 261 123 115 112 101 36 704
J. Mølholm Hansen Denmark 12 185 0.7× 145 1.2× 65 0.6× 74 0.7× 73 0.7× 17 875
AF Lant United Kingdom 18 199 0.8× 69 0.6× 127 1.1× 263 2.3× 131 1.3× 72 1.2k
M. L. Mashford Australia 16 152 0.6× 88 0.7× 74 0.6× 132 1.2× 80 0.8× 39 867
L. Skovsted Denmark 24 408 1.6× 161 1.3× 96 0.8× 153 1.4× 114 1.1× 57 1.6k
Glen D. Park United States 16 386 1.5× 180 1.5× 44 0.4× 114 1.0× 170 1.7× 27 1.1k
Bernard W. Steele United States 18 267 1.0× 99 0.8× 87 0.8× 136 1.2× 146 1.4× 47 962
Rune Dahlqvist Sweden 15 153 0.6× 187 1.5× 86 0.7× 154 1.4× 176 1.7× 27 1.3k
Karin Hedenmalm Sweden 15 96 0.4× 169 1.4× 74 0.6× 96 0.9× 103 1.0× 38 913
Jenifer Wogen United States 12 291 1.1× 56 0.5× 121 1.1× 93 0.8× 71 0.7× 28 714
Lindon Wing Australia 19 172 0.7× 101 0.8× 82 0.7× 106 0.9× 148 1.5× 55 1.1k

Countries citing papers authored by A. Melander

Since Specialization
Citations

This map shows the geographic impact of A. Melander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Melander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Melander more than expected).

Fields of papers citing papers by A. Melander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Melander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Melander. The network helps show where A. Melander may publish in the future.

Co-authorship network of co-authors of A. Melander

This figure shows the co-authorship network connecting the top 25 collaborators of A. Melander. A scholar is included among the top collaborators of A. Melander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Melander. A. Melander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Melander, A., Pietro Folino-Gallo, T Walley, et al.. (2006). Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels. Diabetologia. 49(9). 2024–2029. 32 indexed citations
2.
Hellgren, Margareta, A. Melander, Carl Johan Östgren, L. Råstam, & Ulf Lindblad. (2004). Inverse association between plasma homocysteine, sulphonylurea exposure and physical activity: a community‐based sample of type 2 diabetes patients in the Skaraborg hypertension and diabetes project. Diabetes Obesity and Metabolism. 7(4). 421–429. 14 indexed citations
3.
Östgren, Carl Johan, Ulf Lindblad, Jonas Ranstam, A. Melander, & L. Råstam. (2002). Glycaemic control, disease duration and β‐cell function in patients with Type 2 diabetes in a Swedish community. Skaraborg Hypertension and Diabetes Project. Diabetic Medicine. 19(2). 125–129. 35 indexed citations
4.
Lindblad, Ulf, et al.. (2001). Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project. Diabetes Obesity and Metabolism. 3(1). 25–31. 18 indexed citations
5.
Östgren, Carl Johan, Ulf Lindblad, Jonas Ranstam, A. Melander, & L. Råstam. (2000). Associations between smoking and β‐cell function in a non‐hypertensive and non‐diabetic populationSkaraborg Hypertension and Diabetes Project. Diabetic Medicine. 17(6). 445–450. 67 indexed citations
6.
Carlsten, A., et al.. (1999). Utilisation of codeine and propoxyphene: geographic and demographic variations in prescribing, prescriber and recipient categories. European Journal of Clinical Pharmacology. 55(8). 605–611. 7 indexed citations
7.
Christesen, Henrik Thybo & A. Melander. (1998). Prolonged elimination of tolbutamide in a premature newborn with hyperinsulinaemic hypoglycaemia. European Journal of Endocrinology. 138(6). 698–701. 18 indexed citations
8.
Rydberg, Tony, et al.. (1998). Pharmacokinetics of glibenclamide and its metabolites in diabetic patients with impaired renal function. European Journal of Clinical Pharmacology. 53(6). 429–435. 51 indexed citations
9.
Knowler, William C., G. Sartor, A. Melander, & Bengt Scherstén. (1997). Glucose tolerance and mortality, including a substudy of tolbutamide treatment. Diabetologia. 40(6). 680–686. 43 indexed citations
10.
Ekedahl, Anders, et al.. (1995). Drug prescription attitudes and behaviour of general practitioners. European Journal of Clinical Pharmacology. 47(5). 381–7. 36 indexed citations
11.
Worm, Dorte, Jan Erik Henriksen, Allan Vaag, et al.. (1994). Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period.. The Journal of Clinical Endocrinology & Metabolism. 78(3). 717–721. 57 indexed citations
12.
Ekedahl, Anders, et al.. (1993). Benzodiazepine prescribing patterns in a high-prescribing scandinavian community. European Journal of Clinical Pharmacology. 44(2). 141–146. 21 indexed citations
13.
Dukes, George E., P. K. M. Lunde, A. Melander, et al.. (1990). Clinical pharmacology and primary health care in Europe ? a gap to bridge. European Journal of Clinical Pharmacology. 38(4). 315–318. 22 indexed citations
14.
Seideman, Peter & A. Melander. (1988). EQUIANALGESIC EFFECTS OF PARACETAMOL AND INDOMETHACIN IN RHEUMATOID ARTHRITIS. Lara D. Veeken. 27(2). 117–122. 33 indexed citations
15.
Liedholm, Hans, Anders Lidén, Lisa Kroon, A. Melander, & E Wahlin‐Boll. (1985). Pharmacokinetics of dixyrazine: low bioavailability, improved by food intake.. PubMed. 3(2). 87–92. 10 indexed citations
16.
Melander, A., et al.. (1985). Pharmacokinetic interaction of acetylsalicylic acid and dipyridamole.. British Journal of Clinical Pharmacology. 19(3). 379–383. 8 indexed citations
17.
Fredholm, Bertil B., et al.. (1984). Actions and interactions of acetylsalicylic acid, salicylic acid and diflunisal on platelet aggregation. European Journal of Clinical Pharmacology. 27(2). 165–168. 6 indexed citations
18.
W�hlin-Boll, E., et al.. (1982). Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol. European Journal of Clinical Pharmacology. 22(4). 309–314. 39 indexed citations
19.
Lindholm, Lars, C. Ekdahl, A. Melander, et al.. (1981). Comparison of Diflunisal and Acetylsalicylic Acid in Patients with Rheumatoid Arthritis. Scandinavian Journal of Rheumatology. 10(4). 289–295. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Mølholm Hansen Breakdown of academic impact, for papers by AF Lant Breakdown of academic impact, for papers by M. L. Mashford Breakdown of academic impact, for papers by L. Skovsted Breakdown of academic impact, for papers by Glen D. Park Breakdown of academic impact, for papers by Bernard W. Steele Breakdown of academic impact, for papers by Rune Dahlqvist Breakdown of academic impact, for papers by Karin Hedenmalm Breakdown of academic impact, for papers by Jenifer Wogen Breakdown of academic impact, for papers by Lindon Wing
Rankless by CCL
2026